Latest news
Is GRAIL (GRAL) Fairly Valued Following Galleri Adoption Growth And The FDA Panel Date? - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 05:12:00 GMTFDA panel to review Grail's blood-based cancer test - FirstWord PHARMAFirstWord PHARMA · Fri, 07 Aug 2026 21:32:11 GMTFDA sets advisory panel for Galleri multicancer screening test - MedTech DiveMedTech Dive · Fri, 07 Aug 2026 17:39:34 GMTGRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test - PR NewswirePR Newswire · Fri, 07 Aug 2026 15:05:00 GMTGRAIL Bets Its Galleri Panel Will Set The FDA Bar For Future MCEDs - insights.citeline.cominsights.citeline.com · Fri, 07 Aug 2026 12:26:38 GMTFDA panel’s peptide vote raises alarms among Phoenix-area health experts - AZ FamilyAZ Family · Fri, 07 Aug 2026 03:43:00 GMTAre peptide injections safe? What doctors say after FDA panel vote - WCAXWCAX · Fri, 07 Aug 2026 03:42:00 GMTAn FDA Panel Just Backed 6 Peptides—Here’s What to Know - EatingWellEatingWell · Thu, 06 Aug 2026 22:01:36 GMT